Is COVID-19 a New Hematologic Disease?

SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complication...

Descripción completa

Detalles Bibliográficos
Autores principales: Debuc, Benjamin, Smadja, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217340/
https://www.ncbi.nlm.nih.gov/pubmed/32399806
http://dx.doi.org/10.1007/s12015-020-09987-4
_version_ 1783532593057103872
author Debuc, Benjamin
Smadja, David M.
author_facet Debuc, Benjamin
Smadja, David M.
author_sort Debuc, Benjamin
collection PubMed
description SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies.
format Online
Article
Text
id pubmed-7217340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-72173402020-05-13 Is COVID-19 a New Hematologic Disease? Debuc, Benjamin Smadja, David M. Stem Cell Rev Rep Article SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies. Springer US 2020-05-12 2021 /pmc/articles/PMC7217340/ /pubmed/32399806 http://dx.doi.org/10.1007/s12015-020-09987-4 Text en © Springer Science+Business Media, LLC, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Debuc, Benjamin
Smadja, David M.
Is COVID-19 a New Hematologic Disease?
title Is COVID-19 a New Hematologic Disease?
title_full Is COVID-19 a New Hematologic Disease?
title_fullStr Is COVID-19 a New Hematologic Disease?
title_full_unstemmed Is COVID-19 a New Hematologic Disease?
title_short Is COVID-19 a New Hematologic Disease?
title_sort is covid-19 a new hematologic disease?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217340/
https://www.ncbi.nlm.nih.gov/pubmed/32399806
http://dx.doi.org/10.1007/s12015-020-09987-4
work_keys_str_mv AT debucbenjamin iscovid19anewhematologicdisease
AT smadjadavidm iscovid19anewhematologicdisease

Ejemplares similares